{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:32Z","timestamp":1786119332313,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,31]]},"DOI":"10.1097\/qad.0b013e32832c413d","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T03:25:12Z","timestamp":1247628312000},"page":"1531-1538","source":"Crossref","is-referenced-by-count":72,"title":["Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women"],"prefix":"10.1097","volume":"23","author":[{"given":"Annalene M","family":"Nel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke H","family":"van de Wijgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi H","family":"Kapiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"von Mollendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Geubbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vyankandondera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gileard","family":"Masenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireen","family":"Kiwelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Moyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanique C","family":"Smythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.qai.0000243056.59860.c1","article-title":"Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a phase II clinical trial","volume":"43","author":"Kilmarx","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/154099903322404302","article-title":"The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial","volume":"12","author":"Morrow","year":"2003","journal-title":"J Womens Health (Larchmt)"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2007.04.015","article-title":"Safety, tolerance and acceptability of the Invisible Condom\u00ae and its vaginal applicator in healthy women and their male sexual partners","volume":"76","author":"Trottier","year":"2007","journal-title":"Contraception"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.aids.0000194797.59046.8f","article-title":"Expanded phase 1 safety and acceptability study of 6% cellulose sulfate vaginal gel","volume":"19","author":"Malonza","year":"2005","journal-title":"AIDS"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2105\/AJPH.94.7.1159","article-title":"Acceptability of a microbicide among women and their partners in a 4-country phase I trial","volume":"94","author":"Bentley","year":"2004","journal-title":"Am J Public Health"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1381612043386374","article-title":"Clinical development of microbicides for the prevention of HIV infection","volume":"10","author":"D'Cruz","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.00330-07","article-title":"Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days","volume":"52","author":"Nuttall","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e31802bb35f","article-title":"Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers","volume":"44","author":"Jespers","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.06.026","article-title":"Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide","volume":"325","author":"Woolfson","year":"2006","journal-title":"Int J Pharm"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dki326","article-title":"Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings","volume":"56","author":"Malcolm","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.48.1.337-339.2004","article-title":"In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides","volume":"48","author":"Van Herrewege","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/00002030-200307250-00003","article-title":"Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the nonnucleoside reverse transcriptase inhibitor TMC120 in a gel formulation","volume":"17","author":"Di Fabio","year":"2003","journal-title":"AIDS"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.contraception.2006.09.003","article-title":"Fourteen-day safety and acceptability study of the universal placebo gel","volume":"75","author":"Schwartz","year":"2007","journal-title":"Contraception"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/lc.1999.v133.a94931","article-title":"Benign ethnic neutropenia: what is a normal absolute neutrophil count?","volume":"133","author":"Haddy","year":"1999","journal-title":"J Lab Clin Med"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0004401","article-title":"CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa","volume":"4","author":"Karita","year":"2009","journal-title":"PLoS One"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200907310-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:29Z","timestamp":1786038929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200907310-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832c413d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}